Optimi Health plans Phase III trial of PTSD therapy
Optimi Health is set to initiate a Phase III clinical trial to assess MDMA-assisted therapy to treat individuals living with PTSD in Canada.
The post Optimi Health plans Phase III trial of PTSD therapy appeared first on Clinical Trials Arena .